/Idex%20Corporation%20logo%20and%20lab%20sign-by%20viewimage%20via%20Shutterstock.jpg)
With a market cap of $14 billion, IDEX Corporation (IEX) is a global leader in applied solutions, specializing in advanced fluid and metering technologies, precision health and science solutions, and fire and safety equipment. With a diverse portfolio spanning industries such as life sciences, industrial processing, firefighting, and aerospace, IDEX delivers high-performance, mission-critical components and systems.
Companies valued at $10 billion or more are generally considered “large-cap” stocks, and IDEX fits this criterion perfectly. Known for its innovation and engineering excellence, the Northbrook, Illinois-based company plays a vital role in powering essential industries with highly specialized and precision-engineered products.
IEX saw a 24.8% decline from its 52-week high of $245.70. Shares of the company declined 13.3% over the past three months, a steeper fall compared to the Industrial Select Sector SPDR Fund’s (XLI) marginal dip over the same time frame.

In the longer term, IEX stock is down 11.7% on a YTD basis, lagging behind XLI’s 1.4% rise. In addition, shares of IDEX have dropped 23.7% over the past 52 weeks, compared to XLI’s 7.8% return over the same time frame.
IEX has been trading below its 50-day and 200-day moving average since mid-December 2024.

Despite reporting a better-than-expected Q4 2024 adjusted EPS of $2.04 on Feb. 4, shares of IDEX tumbled 9.6% the next day. The company's Q1 2025 adjusted EPS guidance of $1.60 - $1.65 fell significantly short of analysts' estimate. In addition, revenue of $862.9 million, while up 9% year-over-year, missed expectations, disappointing investors.
However, its rival, Eaton Corporation plc (ETN) has declined 14% on a YTD basis, underperforming IEX. But, ETN fell 8.5% over the past 52 weeks, a smaller drop than IEX.
Despite IDEX’s underperformance over the past year, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from 11 analysts' coverage, and as of writing, IEX is trading below the mean price target of $234.10.